Relationship between OSA and non-alcoholic fatty liver disease

M.R. Bonsignore (Palermo, Italy)

Source: ERS Conference
Number: 75

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M.R. Bonsignore (Palermo, Italy). Relationship between OSA and non-alcoholic fatty liver disease. ERS Conference

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease
Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016
Year: 2017



Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012

Association between obstructive sleep apnea and nonalcoholic fatty liver disease
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019

Association between obstructive sleep apnea and the severity of non-alcoholic fatty liver disease.
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019

Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?
Source: Eur Respir J, 49 (6) 1700546; 10.1183/13993003.00546-2017
Year: 2017



The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease.
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease
Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Year: 2011


In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction
Source: Annual Congress 2012 - Sleep disorders in internal medicine
Year: 2012


1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease
Source: ERJ Open Res, 7 (3) 00103-2021; 10.1183/23120541.00103-2021
Year: 2021



Non-alcoholic fatty liver disease (NAFLD): A new mechanism for co-morbidities in chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016


Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 39s
Year: 2006

Impact of non-alcoholic fatty liver disease on late cardiovascular events and death in Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

The influence of obstructive sleep apneao–induced  intermittant Hypoxia on Non Alcoholic  Fatty  liver.
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017

Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2008; 31: 1024-1029
Year: 2008



Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids?
Source: Eur Respir J 2001; 18: Suppl. 33, 199s
Year: 2001

Free fatty acids levels and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010


Chronic intermittent hypoxia induces features of non alcoholic fatty liver disease (NAFLD) and modifies adipose tissue characteristics in lean mice
Source: International Congress 2014 – Inflammation and obesity: implications for OSA
Year: 2014

An application of omega-3 polyunsaturated fatty acids in treatment of COPD patients with pulmonary hypertension and chronic cor pulmonale
Source: Eur Respir J 2001; 18: Suppl. 33, 251s
Year: 2001

The role of free fatty acids in idiopathic pulmonary fibrosis
Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases
Year: 2017



Noninvasive evaluation of hepatic steatosis and fibrosis in OSA patients at diagnosis
Source: Annual Congress 2012 - Sleep disorders in internal medicine
Year: 2012